A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
作者信息
Knoop M, Cramer D V, Chapman F C, Makowka L
机构信息
Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California.
出版信息
Transplant Proc. 1993 Aug;25(4):2697-8.
PMID:8356719
Abstract
摘要
相似文献
1
A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
Transplant Proc. 1993 Aug;25(4):2697-8.
2
Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
Transplant Proc. 1993 Feb;25(1 Pt 1):706-7.
3
Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
Transplantation. 1994 Apr 15;57(7):1072-80.
4
Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
Transplant Proc. 1993 Jun;25(3 Suppl 2):65-6.
5
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
Transplant Proc. 1996 Apr;28(2):950-1.
6
Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
Transplant Proc. 1995 Feb;27(1):451-2.
7
The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Transplantation. 1992 Feb;53(2):303-8. doi: 10.1097/00007890-199202010-00009.
8
Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
Transplant Proc. 1994 Aug;26(4):2333-5.
9
Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
Transplant Proc. 1993 Jun;25(3 Suppl 2):57-8.
10
Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.
Transplant Proc. 1993 Jun;25(3 Suppl 2):59-60.
Zotero 插件